Warrants - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended
	May 06, 2024	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Dec. 31, 2024
Class of Warrant or Right [Line Items]
Additional Paid-in Capital adjustment from warrant issuance			$ 5,031
Warrant liability					$ 28,910
Proceeds from the exercise of warrants				$ 35,745
Common Warrants
Class of Warrant or Right [Line Items]
Warrant liability					$ 28,910
Change in fair value of warrant liability		$ 2,000		27,100
Registered Direct Offering \| Common Warrants
Class of Warrant or Right [Line Items]
Warrants issued to purchase common shares	13,078,509
Exercise price of warrants	$ 3.5
Proceeds from the exercise of warrants				$ 54,300
Registered Direct Offering \| Pre-funded Warrants
Class of Warrant or Right [Line Items]
Warrants issued to purchase common shares	4,144,085	4,131,828		4,131,828
Combined offering price per share	$ 1.7311
Additional Paid-in Capital adjustment from warrant issuance	$ 5,000
Exercise price of warrants	$ 0.0001
Purchase price of warrants	3.4999
Number of warrants exercised		0		0
Warrants outstanding		8,275,913		8,275,913
Registered Direct Offering \| Common Stock and Common Warrants
Class of Warrant or Right [Line Items]
Combined offering price per share	$ 1.7312
Registered Direct Offering \| Common Stock and Common Warrants \| Common Stock
Class of Warrant or Right [Line Items]
Shares issued in transaction	13,512,699
Registered Direct Offering \| Common Stock and Common Warrants \| Common Warrants
Class of Warrant or Right [Line Items]
Warrants issued to purchase common shares	13,078,509
Registered Direct Offering \| Pre-funded and Common Warrants
Class of Warrant or Right [Line Items]
Combined offering price per share	$ 1.7311
Registered Direct Offering \| Pre-funded and Common Warrants \| Common Warrants
Class of Warrant or Right [Line Items]
Warrants issued to purchase common shares	4,010,927
Registered Direct Offering \| Pre-funded and Common Warrants \| Pre-funded Warrants
Class of Warrant or Right [Line Items]
Warrants issued to purchase common shares	4,144,085

Corvus Pharmaceuticals, Inc. 10-Q